RP
PFE icon

Raelipskie Partnership’s Pfizer PFE Stock Holding History

Raelipskie Partnership’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$312K Sell
11,117
-1,347
-11% -$35.9K 0.13% 61
2025
Q4 		$310K Buy
12,464
+578
+5% +$14.6K 0.13% 60
2025
Q3 		$303K Sell
11,886
-472
-4% -$11.7K 0.13% 61
2025
Q2 		$300K Buy
12,358
+328
+3% +$7.65K 0.14% 61
2025
Q1 		$305K Sell
12,030
-2,200
-15% -$57.6K 0.16% 61
2024
Q4 		$378K Sell
14,230
-660
-4% -$17.9K 0.19% 58
2024
Q3 		$431K Sell
14,890
-825
-5% -$24.1K 0.21% 58
2024
Q2 		$440K Buy
15,715
+250
+2% +$6.88K 0.23% 57
2024
Q1 		$429K Sell
15,465
-8,128
-34% -$226K 0.24% 56
2023
Q4 		$679K Buy
+23,593
New +$713K 0.41% 49

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Raelipskie Partnership's PFE Position: Q1 2026 in Review

Raelipskie Partnership reduced its Pfizer (PFE) stake by 11% in Q1 2026, selling an estimated $35.9K and leaving 11,117 shares worth $312K. The position accounts for 0.13% of the portfolio, ranked #61.

Raelipskie Partnership first reported a position in PFE in Q4 2023 and has held it in 10 quarters since. The position peaked at $679K in Q4 2023. 2,938 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Raelipskie Partnership held 11,117 shares of Pfizer worth $312K as of Q1 2026.
  • Raelipskie Partnership sold 1,347 Pfizer shares in Q1 2026, an estimated $35.9K.
  • Pfizer made up 0.13% of Raelipskie Partnership's portfolio in Q1 2026, its #61 holding.
  • Raelipskie Partnership first reported a position in Pfizer in Q4 2023 and has held it in 10 quarters since.
  • Raelipskie Partnership's Pfizer position peaked at $679K in Q4 2023.
  • 2,938 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Raelipskie Partnership's 13F filing for Q1 2026, filed 29 Apr 2026.